May 2007
Journal of Business (10756124);5/3/2007, Vol. 22 Issue 10, p2
Trade Publication
The article offers business news briefs in Spokane, Washington. Northwest Bancorp Inc. reported a net income of $495,000 for the first quarter of 2007. Avista Corp. filed an application to the Washington Utilities and Transportation Commission regarding the rate increases averaging 15.85% for electronic customers and 2.27% for natural gas customers. Jubilant Organosys Ltd. has acquired Hollister-Stier Laboratories LLC for $122.5 million.


Related Articles

  • Drug giant completes purchase of Hollister-Stier.  // Journal of Business (10756124);6/14/2007, Vol. 22 Issue 13, pA2 

    The article reports on the announcement of Jubilant Organosys Ltd. that it has completed the purchase of Spokane, Washington-based Hollister-Stier Laboratories LLC. Jubilant acquired the company for $122 million and also agreed to pay an $18.7 million reimbursement to cover the costs of a...

  • Jubilant Completes Hollister Acquisition. Ramesh, Deepti // Chemical Week;6/13/2007, Vol. 169 Issue 20, p37 

    The article reports on the acquisition of Hollister-Stier Laboratories, a sterile injectables contract manufacturer, by Jubilant Organosys, a pharmaceutical custom research and manufacturing services (CRAMS) company, for $122.5 million. The deal is the largest overseas acquisition in contract...

  • Hollister, RAHCO sales hold promise.  // Journal of Business (10756124);5/3/2007, Vol. 22 Issue 10, p8 

    The author reflects on the promising sales of Hollister-Stier Laboratories LLC and RAHCO International Inc. amidst their approaching acquisition from larger companies. He notes that Jubilant Organosys Ltd. and FLSmidth & Co. A/S would be beneficial for Hollister-Stier and RAHCO because of their...

  • IN THE NEWS.  // Journal of Business (10756124);5/29/2008, Vol. 23 Issue 12, p2 

    The article offers news briefs related to businesses and industries in the U.S. Hollister-Stier Laboratories LLC has announced the resignation of chief executive officer Anthony Bonanzino. BookRags Inc., which operates a Web site has been acquired by Ambassadors Inc. A renewal of the 0.3 percent...

  • Tightening the Connection with India. Ruth, João-Pierre S. // njbiz;11/13/2006, Vol. 19 Issue 46, p15 

    The article features Clinsys, a company which provides clinical research and data-management services to drugmakers, acquired by India's Jubilant Organosys. Clinsys has 150 workers across the U.S. and about 100 employees in India. The company created a business and culture program for employees...

  • Jubilant focuses on life sciences. Hariharan, Malini; Viswanathan, Prema // Asian Chemical News;10/24/2005, Vol. 11 Issue 511, p8 

    Focuses on the decision of Jubilant Organosys to increase its share of the pharmaceuticals and life sciences sector in India in 2005. Performance of the pharmaceuticals and life sciences sector in the financial year ended March 31, 2005; Merger and acquisition activities of the company;...

  • Jubilant Organos Buys European Companies.  // Chemical Market Reporter;5/3/2004, Vol. 265 Issue 18, p10 

    Reports that Noida, India-based Jubilant Organosys Ltd. plans to acquire two European companies active in pharmaceutical formulation. Business expansions; Global capital markets; Pharmaceutical manufacturing business.

  • Jubilant to buy Draxis for $255M; Emeritus adds 24 new facilities.  // Medical Device Daily;4/7/2008, Vol. 12 Issue 67, p1 

    This article reports on the intention of Jubilant Organosys to acquire Draxis Health in 2008. Jubilant offered a price of $6 per share in cash. The arrangement agreement contains customary non-solicitation provisions, but permits Draxis to terminate the arrangement and accept an unsolicited...

  • Jubilant Buys Contract Research Organization in the U.S. Scott, Alex // Chemical Week;10/19/2005, Vol. 167 Issue 34, p26 

    The article reports on the acquisition of Target Research Associates by Jubilant Organosys. According to Jubilant, the deal will help it to expand its contract research organization services globally. Jubilant predicts that it will be able to accelerate clinical trials and reduce costs at...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics